Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:48 AM
Ignite Modification Date:
2025-12-25 @ 3:48 AM
NCT ID:
NCT06239402
Eligibility Criteria:
Inclusion Criteria:
* Patient with non valvular atrial fibrillation with direct oral anticoagulants therapy
* Patient on antiplatelet therapy (acetylsalicylic acid and/or inhibitor of the P2Y12 platelet receptor)
* Patient hospitalized for percutaneous coronary intervention in the previous 7 days
* Age ≥18 years
* Estimated life expectancy ≥ 12 months
* Ability to give informed consent
Exclusion Criteria:
* Patients who have contraindications to direct oral anticoagulants therapy
* Patients who are indicated for direct oral anticoagulants therapy for reasons other than non valvular atrial fibrillation
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06239402
Study Brief:
Protocol Section:
NCT06239402